169 related articles for article (PubMed ID: 37727304)
1. B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review.
Cavalcante PN; Kanhouche G; Rosa VEE; Campos CM; Lopes MP; Lopes MAAAM; Sampaio RO; de Brito Júnior FS; Tarasoutchi F; Abizaid AAC
Front Cardiovasc Med; 2023; 10():1182530. PubMed ID: 37727304
[TBL] [Abstract][Full Text] [Related]
2. The interaction of forced expiratory volume in 1 s and N-terminal pro-B-type natriuretic peptide with outcomes after transcatheter aortic valve replacement.
Crestanello JA; Greason KL; Mathew J; Eleid MF; Nkomo VT; Rihal CS; Bagameri G; Holmes DR; Pislaru SV; Sandhu GS; Lee AT; King KS; Alkhouli M
Eur J Cardiothorac Surg; 2023 Apr; 63(4):. PubMed ID: 36645236
[TBL] [Abstract][Full Text] [Related]
3. Different impact of aortic regurgitation assessed by aortic root angiography after transcatheter aortic valve implantation according to baseline left ventricular ejection fraction and N-terminal pro-B-type natriuretic peptide.
Kaneko H; Hoelschermann F; Schau T; Tambor G; Neuss M; Butter C
Cardiovasc Interv Ther; 2018 Jul; 33(3):232-238. PubMed ID: 28567700
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of NT-pro BNP and CT-ANP as markers of concentric hypertrophy in dogs with a model of compensated aortic stenosis.
Hori Y; Tsubaki M; Katou A; Ono Y; Yonezawa T; Li X; Higuchi SI
J Vet Intern Med; 2008; 22(5):1118-23. PubMed ID: 18681918
[TBL] [Abstract][Full Text] [Related]
5. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
Potocki M; Mair J; Weber M; Hamm C; Burkard T; Hiemetzberger R; Peters K; Jander N; Cron TA; Hess N; Hoffmann A; Gekeler H; Gohlke-Bärwolf C; Buser P; Mueller C
Am J Cardiol; 2009 Aug; 104(4):559-64. PubMed ID: 19660612
[TBL] [Abstract][Full Text] [Related]
6. Relationship between N-terminal pro-B type natriuretic peptide and extensive echocardiographic parameters in mild to moderate aortic stenosis.
Cemri M; Arslan U; Kocaman SA; Cengel A
J Postgrad Med; 2008; 54(1):12-6. PubMed ID: 18296798
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of N-Terminal Pro-form B-Type Natriuretic Peptide in Patients With Moderate Aortic Stenosis.
Ito S; Miranda WR; Jaffe AS; Oh JK
Am J Cardiol; 2020 May; 125(10):1566-1570. PubMed ID: 32204871
[TBL] [Abstract][Full Text] [Related]
8. Effect of B-type natriuretic peptides on long-term outcomes after transcatheter aortic valve implantation.
Koskinas KC; O'Sullivan CJ; Heg D; Praz F; Stortecky S; Pilgrim T; Buellesfeld L; Jüni P; Windecker S; Wenaweser P
Am J Cardiol; 2015 Nov; 116(10):1560-5. PubMed ID: 26428025
[TBL] [Abstract][Full Text] [Related]
9. Correlation of N-terminal-pro-brain natriuretic peptide with postoperative outcomes of older patients undergoing transcatheter aortic valve replacement.
Huang YC; Chang HH; Chen PL; Chu CM; Tsai JC; Wang KY
J Chin Med Assoc; 2023 May; 86(5):479-484. PubMed ID: 36930846
[TBL] [Abstract][Full Text] [Related]
10. Relationship between prosthesis-patient mismatch and pro-brain natriuretic peptides after aortic valve replacement.
Melina G; Angeloni E; Benedetto U; Refice S; Miceli A; Miele C; Ciavarella GM; Sinatra R
J Heart Valve Dis; 2010 Mar; 19(2):171-6. PubMed ID: 20369499
[TBL] [Abstract][Full Text] [Related]
11. N-terminal pro-B-type natriuretic peptide and outcomes in type B aortic dissection in China: a retrospective multicentre study.
Luo C; Zhou J; Xiong S; Kang Z; Zhang J; Sun Y; Qin B; Fang K
BMJ Open; 2019 Sep; 9(9):e029885. PubMed ID: 31492783
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptides in patients with aortic stenosis.
Qi W; Mathisen P; Kjekshus J; Simonsen S; Bjørnerheim R; Endresen K; Hall C
Am Heart J; 2001 Oct; 142(4):725-32. PubMed ID: 11579366
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
14. Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-B-type natriuretic peptide.
Spargias K; Alexopoulos E; Thomopoulou S; Dimopoulos A; Manginas A; Pavlides G; Voudris V; Karatassakis G; Athanassopoulos G; Cokkinos DV
Am J Cardiol; 2009 Sep; 104(6):846-9. PubMed ID: 19733722
[TBL] [Abstract][Full Text] [Related]
15. Pro B-type natriuretic peptide plasma value: a new criterion for the prediction of short- and long-term outcomes after transcatheter aortic valve implantation.
López-Otero D; Trillo-Nouche R; Gude F; Cid-Álvarez B; Ocaranza-Sanchez R; Alvarez MS; Lear PV; Gonzalez-Juanatey JR
Int J Cardiol; 2013 Sep; 168(2):1264-8. PubMed ID: 23280329
[TBL] [Abstract][Full Text] [Related]
16. The role of biomarkers in valvular heart disease: focus on natriuretic peptides.
Bergler-Klein J; Gyöngyösi M; Maurer G
Can J Cardiol; 2014 Sep; 30(9):1027-34. PubMed ID: 25151285
[TBL] [Abstract][Full Text] [Related]
17. Natriuretic peptides in the management of aortic stenosis.
Bergler-Klein J
Curr Cardiol Rep; 2009 Mar; 11(2):85-93. PubMed ID: 19236823
[TBL] [Abstract][Full Text] [Related]
18. N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide for identifying coronary artery disease and left ventricular hypertrophy in ambulatory chronic kidney disease patients.
Khan IA; Fink J; Nass C; Chen H; Christenson R; deFilippi CR
Am J Cardiol; 2006 May; 97(10):1530-4. PubMed ID: 16679099
[TBL] [Abstract][Full Text] [Related]
19. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
Suzuki S; Sugiyama S
Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
[TBL] [Abstract][Full Text] [Related]
20. Left Ventricular Hypertrophy and Biomarkers of Cardiac Damage and Stress in Aortic Stenosis.
Stein EJ; Fearon WF; Elmariah S; Kim JB; Kapadia S; Kumbhani DJ; Gillam L; Whisenant B; Quader N; Zajarias A; Welt FG; Bavry AA; Coylewright M; Piana RN; Mallugari RR; Clark DE; Patel JN; Gonzales H; Gupta DK; Vatterott A; Jackson N; Huang S; Lindman BR
J Am Heart Assoc; 2022 Apr; 11(7):e023466. PubMed ID: 35301869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
